Chicago, March 08, 2024 (GLOBE NEWSWIRE) -- Chicago, Illinois -
IV Solution & Ketamine Centers of Chicago, a dominant medical clinic well-known for its expertise in pioneering intravenous treatments, recently declared a significant expansion of its treatment repertoire. This included the integration of the innovative Stellate Ganglion Block (SGB) therapy for Post-Traumatic Stress Disorder (PTSD). This noteworthy media story marks an optimistic stride for the broader healthcare community, providing a glimmer of hope for the countless adults globally who are struggling with the crippling effects of PTSD.
The clinic has gained high recognition due to its exemplary initiatives in the medical realm. These initiatives underscore a profound expertise in addressing and managing a spectrum of mental health issues and chronic pain conditions. This includes the proficient delivery of fibromyalgia management solutions which, notably, has generated substantial attention in the medical field. The Stellate Ganglion Block therapy, a noteworthy addition to their treatment portfolio, heralds a pivotal discovery in PTSD therapy. This procedure involves an anesthetic injection into the patient's neck that targets and impedes nerve signals intimately associated with PTSD symptoms. Preliminary research on the potential of this SGB approach has shown tremendous promise for assuaging the discomfort experienced by individuals diagnosed with PTSD.
Dr. Bal Nandra, CEO of IV Solution & Ketamine Centers, emphasized their steadfast commitment to unearthing and implementing unique solutions to combat disabling conditions like PTSD. "We are immensely proud to add SGB therapy to our range of treatments. We remain resolute in our mission to introduce transformative changes to the lives of our patients with our expanding range of effective treatment choices," Dr. Nandra stated.
The clinic also provides a variety of influential therapies aimed at tackling various mental health issues, beyond their newly introduced SGB treatment. These include Intravenous Ketamine Therapy, scientifically recognized for its effectiveness in addressing depression, anxiety, and bipolar disorders. Additionally, they offer NAD+ Therapy, meticulously crafted to enhance crucial cognitive functions such as mental clarity, alertness, concentration, and memory.
Recognizing the financial challenges that often accompany healthcare costs, IV Solution & Ketamine Centers have teamed up with CareCredit, a financial aid organization. This partnership aims to extend financial assistance to potential patients, ensuring their transformative treatments remain reachable to a broader patient demographic who might otherwise struggle to afford them.